Immune complex disease with a lupus-like pattern of deposition in an antinuclear antibody-negative patient.

Immune complex-mediated glomerulonephritis can be caused by a multitude of disease processes and may manifest in a variety of histologic patterns. Lupus nephritis is an immune complex disease, the diagnosis of which requires that the affected patient have systemic lupus erythematosus (SLE). In the absence of SLE, the finding of glomerulonephritis with certain patterns of immune complex deposition characteristic of lupus nephritis has been referred to as lupus-like glomerulonephritis. Immunoglobulin G (IgG), IgA, IgM, complement C3, and C1q deposition in glomerular immune deposits is one such pattern. We report a case of immune complex disease in a primarily membranous distribution with mesangial, subendothelial, and tubular basement membrane deposits with IgG, IgA, IgM, C3, and C1q deposition in a patient with proteinuria, photosensitive dermatitis, and a positive lupus anticoagulant test. The patient had 3 of the clinical criteria for SLE, thus failing to meet the diagnosis based on the American College of Rheumatology definition. In this case, a diagnosis of lupus-like glomerulonephritis was made after other causes of membranous glomerulopathy were excluded. This teaching case highlights the broad differential diagnosis of this pattern of injury and reviews similar cases in the literature.

[1]  A. Fogo,et al.  Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis? , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[2]  Ju Han Kim,et al.  Differential diagnosis of lupus and primary membranous nephropathies by IgG subclass analysis. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[3]  V. D’Agati,et al.  Renal-limited 'lupus-like' nephritis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  H. Debiec,et al.  PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. , 2011, The New England journal of medicine.

[5]  M. Bülbül,et al.  An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy , 2010, Rheumatology International.

[6]  V. D’Agati,et al.  Proliferative glomerulonephritis with monoclonal IgG deposits. , 2009, Journal of the American Society of Nephrology : JASN.

[7]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[8]  C. Suh,et al.  An Antinuclear Antibody-Negative Patient With Lupus Nephritis , 2009, The Korean journal of internal medicine.

[9]  刘双信,et al.  Membranous nephropathy , 2008 .

[10]  O. Rekvig,et al.  Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[11]  N. Cengiz,et al.  Full-house nephropathy in a patient with negative serology for lupus , 2006, Rheumatology International.

[12]  J. Feehally,et al.  Distinguishing C1q nephropathy from lupus nephritis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[14]  G. Markowitz Dysproteinemia and the Kidney , 2004, Advances in anatomic pathology.

[15]  R. Cervera,et al.  Anti-chromatin (anti-nucleosome) autoantibodies. , 2002, Autoimmunity reviews.

[16]  M. Kobayashi,et al.  Delayed onset of systemic lupus erythematosus in a child with endothelial tubuloreticular inclusion. , 2001, Clinical nephrology.

[17]  D. Pisetsky Anti-DNA and autoantibodies. , 2000, Current Opinion in Rheumatology.

[18]  M. V. van Velthuysen,et al.  Glomerulopathy Associated with Parasitic Infections , 2000, Clinical Microbiology Reviews.

[19]  G. Rizzoni,et al.  Delayed onset of systemic lupus erythematosus in patients with ”full-house” nephropathy , 1999, Pediatric Nephrology.

[20]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[21]  A. Komatsuda,et al.  IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. , 1997, Kidney international.

[22]  J. Jennette,et al.  Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. , 1983, Kidney international.

[23]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[24]  E. Jones,et al.  Nonsystemic mesangiopathic glomerulonephritis with "full house" immunofluorescence. Pathological and clinical observation in five patients. , 1982, American journal of clinical pathology.

[25]  Maddison Pj ANA-negative SLE. , 1982 .